Video

Dr. Thiel on Protecting Patients and Providers From COVID-19

David D. Thiel, MD, chair, discusses the measures that are being taken to protect patients and providers from the coronavirus disease 2019 (COVID-19).

David D. Thiel, MD, chair, Department of Urology, Mayo Clinic, discusses the measures that are being taken to protect patients and providers from the coronavirus disease 2019 (COVID-19).

It is important to protect all providers from COVID-19 exposure, particularly anesthesiologists who perform aerosolizing procedures such as intubation, says Thiel. Moreover, by separating COVID-19–positive patients from COVID-19–negative patients in the hospital, health care systems can reduce the risk of patient exposure to the virus.

Testing is a critical component of ensuring that COVID-19–positive patients can be distanced from COVID-19–negative patients. At Mayo Clinic, every patient who is scheduled for surgery receives a nasal swab to ensure that they don’t have the virus, says Thiel. These measures are particularly important for patients with cancer who are already immunocompromised but need to come into the clinic for treatment. Telehealth visits have helped reduce the volume of patients who come into the cancer center, but it is not appropriate for everyone.

Despite containment efforts, the virus is not likely to disappear, meaning that communities will have to learn to modify their behaviors to reduce the risk of further spread, concludes Thiel.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge
Video

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

May 14th 2025 - May 15th 2026

online-activity
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Arizona
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Arizona

May 13th 2025 - Jun 18th 2025

online-activity
16th Annual International Symposium on Ovarian Cancer and Other Gynecological Malignancies™
Video

16th Annual International Symposium on Ovarian Cancer and Other Gynecological Malignancies™

May 9th 2025 - Jun 14th 2025

online-activity